SNDA trades 14.9% below Wall Street's consensus target of $41.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SNDA achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Sonida Senior Living, Inc. (SNDA) has a Wall Street consensus price target of $41.33, based on estimates from 4 covering analysts. With the stock currently trading at $35.96, this represents a potential upside of +14.9%. The company has a market capitalization of $719M.
Analyst price targets range from a low of $37.00 to a high of $45.00, representing a 19% spread in expectations. The median target of $42.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, SNDA trades at a trailing P/E of -8.5x. Analysts expect EPS to grow +32.5% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ENSGThe Ensign Group, Inc. | $9.0B | $153.65 | $222.33 | +44.7% | Buy | 20.3x | 13 |
BKDBrookdale Senior Living Inc. | $3.2B | $13.65 | $18.75 | +37.4% | Buy | — | 12 |
SGRYSurgery Partners, Inc. | $1.9B | $14.55 | $19.33 | +32.9% | Buy | 33.9x | 22 |
CTRECareTrust REIT, Inc. | $8.8B | $37.06 | $44.25 | +19.4% | Buy | 24.8x | 19 |
SHCSotera Health Company | $4.5B | $15.82 | $21.50 | +35.9% | Buy | 16.3x | 12 |
NHCNational HealthCare Corporation | $3.1B | $201.53 | — | — | — | 25.3x | — |
ADUSAddus HomeCare Corporation | $1.8B | $94.23 | $122.00 | +29.5% | Buy | 13.5x | 16 |
WELLWelltower Inc. | $144.8B | $206.65 | $237.80 | +15.1% | Buy | 71.3x | 34 |
VTRVentas, Inc. | $38.8B | $81.61 | $95.86 | +17.5% | Buy | 130.8x | 32 |
OHIOmega Healthcare Investors, Inc. | $13.3B | $44.53 | $50.43 | +13.2% | Hold | 22.4x | 28 |
Quick answers to the most common questions about buying SNDA stock.
Sonida Senior Living, Inc. (SNDA) has a consensus 12-month price target of $41.33, implying 14.9% upside from $35.96. The 4 analysts covering SNDA see moderate appreciation potential.
SNDA has a consensus rating of "Hold" based on 4 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $41.33 implies 14.9% upside from current levels.
SNDA's current price is $35.96 with a consensus target of $41.33 (14.9% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $45 for SNDA, while the most conservative target is $37. The consensus of $41.33 represents the median expectation. These targets typically reflect 12-month expectations.
SNDA is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SNDA stock forecast based on 4 Wall Street analysts shows a consensus price target of $41.33, with estimates ranging from $37 (bear case) to $45 (bull case). The median consensus rating is "Hold".
Wall Street analysts are optimistic on SNDA, with a "Hold" consensus rating and $41.33 price target (14.9% upside). 1 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SNDA analyst price targets range from $37 to $45, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $41.33 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.